Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-Jun-2026 21:16 ET (25-Jun-2026 01:16 GMT/UTC)
Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a promising avenue to treat cancer, according to new research by UTHealth Houston.
The American Cancer Society today released its annual “Cancer Statistics, 2026” and “Cancer Facts & Figures 2026” report — the first national snapshot of this year’s cancer trends. Experts from City of Hope®, one of the country’s leading cancer research and treatment institutions, are available immediately for interviews to help interpret key trends and provide context for how these findings affect patients, families and the future of cancer care. We also have patients available for interviews.
An international team of scientists analysed the ongoing colonization by two retroviruses of the germline of koalas and resulting deaths from cancer in multi-generational pedigrees of over 100 koalas in US and European Zoos. In the journal Nature Communications, they describe the genome sequencing of the koalas and their analysis of integration in or near genes involved in cancer, new germline integrations within a single generation, and deaths from cancer caused by the retroviral integration. Based on this work, the scientists calculated genetic risk scores (GRS) that can help guide koala breeding programs and thereby benefit koala conservation efforts.
The FXYD proteins (FXYD domain-containing ion transport regulators) are a family of seven distinct proteins that play crucial roles in regulating Na+/K+-ATPase (NKA) activity. Each of these proteins is characterized by a conserved 35-amino-acid FXYD domain, essential for their functions, and exhibits tissue-specific expression, contributing to diverse roles in various tissues.
Research over the years has highlighted the role of the FXYD proteins in regulating numerous physiological processes, including ion transport, neuronal activity, cell adhesion, and migration; conversely, their altered expression has been implicated in the progression of various diseases, such as cancer, neurological, cardiovascular, and renal diseases, and others. Understanding the FXYD proteins and their underlying regulatory mechanisms may therefore aid in identifying novel therapeutic targets.